Advanced Search

National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No. 6) (No. PB 40 of 2011)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.6)
Instrument number PB 40 of 2011
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                       23          May  2011
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.6).
         (2)   This Determination may also be cited as PB 40 of 2011.
2              Commencement
                This Determination commences on 1 June 2011.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
[1]     Schedule 1, after item dealing with Saquinavir
                  
Insert
 
          Saxagliptin
 
[2]     Schedule 1, after item dealing with Strontium
                  
Omit
 
          Sulfacetamide
 
 
 
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.